Literature DB >> 25981303

Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.

Sang-Min Lee1, Jason M Booe1, Augen A Pioszak2.   

Abstract

The G protein-coupled receptor (GPCR) superfamily constitutes the largest collection of cell surface signaling proteins with approximately 800 members in the human genome. GPCRs regulate virtually all aspects of physiology and they are an important class of drug targets with ~30% of drugs on the market targeting a GPCR. Breakthroughs in GPCR structural biology in recent years have significantly expanded our understanding of GPCR structure and function and ushered in a new era of structure-based drug design for GPCRs. Crystal structures for nearly thirty distinct GPCRs are now available including receptors from each of the major classes, A, B, C, and F. These structures provide a foundation for understanding the molecular basis of GPCR pharmacology. Here, we review structural mechanisms of ligand recognition and selectivity of GPCRs with a focus on selected examples from classes A, B, and C, and we highlight major unresolved questions for future structural studies.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GPCR structure; GPCR subtype; Ligand recognition; Subtype selectivity; X-ray crystallography

Mesh:

Substances:

Year:  2015        PMID: 25981303      PMCID: PMC4584177          DOI: 10.1016/j.ejphar.2015.05.013

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  84 in total

Review 1.  Complementarity of delta opioid ligand pharmacophore and receptor models.

Authors:  H I Mosberg
Journal:  Biopolymers       Date:  1999       Impact factor: 2.505

2.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

3.  Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function.

Authors:  C G Nebigil; P Hickel; N Messaddeq; J L Vonesch; M P Douchet; L Monassier; K György; R Matz; R Andriantsitohaina; P Manivet; J M Launay; L Maroteaux
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

4.  Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+.

Authors:  Daisuke Tsuchiya; Naoki Kunishima; Narutoshi Kamiya; Hisato Jingami; Kosuke Morikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

5.  Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.

Authors:  S P Vickers; C T Dourish; G A Kennett
Journal:  Neuropharmacology       Date:  2001-08       Impact factor: 5.250

6.  Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop.

Authors:  G Bonner; F Meng; H Akil
Journal:  Eur J Pharmacol       Date:  2000-09-01       Impact factor: 4.432

Review 7.  Ergotamine in the acute treatment of migraine: a review and European consensus.

Authors:  P Tfelt-Hansen; P R Saxena; C Dahlöf; J Pascual; M Láinez; P Henry; H Diener; J Schoenen; M D Ferrari; P J Goadsby
Journal:  Brain       Date:  2000-01       Impact factor: 13.501

Review 8.  The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.

Authors:  J S Mogil; G W Pasternak
Journal:  Pharmacol Rev       Date:  2001-09       Impact factor: 25.468

9.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor.

Authors:  N Kunishima; Y Shimada; Y Tsuji; T Sato; M Yamamoto; T Kumasaka; S Nakanishi; H Jingami; K Morikawa
Journal:  Nature       Date:  2000-10-26       Impact factor: 49.962

Review 10.  Molecular biology of serotonin receptors structure and function at the molecular level.

Authors:  Wesley K Kroeze; Kurt Kristiansen; Bryan L Roth
Journal:  Curr Top Med Chem       Date:  2002-06       Impact factor: 3.295

View more
  14 in total

1.  Structure-based development of a subtype-selective orexin 1 receptor antagonist.

Authors:  Jan Hellmann; Matthäus Drabek; Jie Yin; Jakub Gunera; Theresa Pröll; Frank Kraus; Christopher J Langmead; Harald Hübner; Dorothee Weikert; Peter Kolb; Daniel M Rosenbaum; Peter Gmeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

2.  Direct Modulation of Heterotrimeric G Protein-coupled Signaling by a Receptor Kinase Complex.

Authors:  Meral Tunc-Ozdemir; Daisuke Urano; Dinesh Kumar Jaiswal; Steven D Clouse; Alan M Jones
Journal:  J Biol Chem       Date:  2016-05-27       Impact factor: 5.157

3.  Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Authors:  Sang-Min Lee; Debbie L Hay; Augen A Pioszak
Journal:  J Biol Chem       Date:  2016-02-19       Impact factor: 5.157

4.  Photoaffinity Labeling of the Human A2A Adenosine Receptor and Cross-link Position Analysis by Mass Spectrometry.

Authors:  Hideyuki Muranaka; Takaki Momose; Chiaki Handa; Tomonaga Ozawa
Journal:  ACS Med Chem Lett       Date:  2017-05-17       Impact factor: 4.345

5.  Structure and selectivity engineering of the M1 muscarinic receptor toxin complex.

Authors:  Shoji Maeda; Jun Xu; Francois Marie N Kadji; Mary J Clark; Jiawei Zhao; Naotaka Tsutsumi; Junken Aoki; Roger K Sunahara; Asuka Inoue; K Christopher Garcia; Brian K Kobilka
Journal:  Science       Date:  2020-07-10       Impact factor: 47.728

6.  Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.

Authors:  Jian-Xin Cheng; Tao Cheng; Wei-Hua Li; Gui-Xia Liu; Wei-Liang Zhu; Yun Tang
Journal:  Acta Pharmacol Sin       Date:  2017-10-19       Impact factor: 6.150

7.  Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor.

Authors:  Taichi Nakamura; Irene Ramos-Álvarez; Tatiana Iordanskaia; Paola Moreno; Samuel A Mantey; R T Jensen
Journal:  Biochem Pharmacol       Date:  2016-06-23       Impact factor: 5.858

Review 8.  Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.

Authors:  Wen-Ting Peng; Wu-Yi Sun; Xin-Ran Li; Jia-Chang Sun; Jia-Jia Du; Wei Wei
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

9.  Full rescue of an inactive olfactory receptor mutant by elimination of an allosteric ligand-gating site.

Authors:  Kanika Sharma; Sabine Balfanz; Arnd Baumann; Sigrun Korsching
Journal:  Sci Rep       Date:  2018-06-25       Impact factor: 4.379

Review 10.  Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research.

Authors:  Zhixiang Wang
Journal:  Int J Mol Sci       Date:  2016-01-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.